MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

HealthEquity Stock

HealthEquity, Inc.

HQYNASDAQBeobachtung
US$92.03
-0.5% today

Company data

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
United States
CEO
Scott R. Cutler
Employees
2,814
Market cap
$7.6 B
IPO
31/07/2014

Headquartered in Draper, Utah, HealthEquity, Inc. operates within the Healthcare sector as a provider of technology-powered service platforms for both individual consumers and employers across the United States. The company offers cloud-based solutions designed to assist individuals in overseeing their healthcare…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

HealthEquity stock: price history

16/10/25+1.1 %16/10/26

1D

-0.5%

1W

-0.6%

1M

-4.1%

6M

+7.0%

YTD

+0.5%

1Y

+1.1%

2Y

+7.2%

5Y

+45.7%

10Y

+151.4%

Next earnings date

Next earnings date

02/12/2026 (in 46 days)

Volatility around earnings

~45% stronger price swings than usual

HealthEquity stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.

Business model & megatrends

Business model

Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.

Why this value? Details with Pro only.

1 more assignment (Enabler/Second row) Pro-only.

HealthEquity offers technology-enabled service solutions and platforms for managing healthcare spending and savings. The company supports both individuals and employers in the United States through cloud-based solutions that enable users to pay medical bills, compare costs, and manage preventive care services. A key focus area is the administration of account models such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). The offering also includes investment opportunities for savings, automated advisory services, and COBRA services. Revenue is generated through financial services, service fees, and transaction volumes from debit and credit cards.

Revenue model
Mixed
Recurring revenue
High
Pricing power
Strong
Moat
Wide
Moat type
Switching costs
Capital intensity
Low
Customer concentration
Unknown

Ask the agents about HealthEquity

Analyst assessment of HealthEquity

PRICE TARGET LOW

US$108.00

CONSENSUS

US$117.00

MEDIAN

US$113.00

PRICE TARGET HIGH

US$142.00

1

STRONG BUY

24

BUY

1

HOLD

1

SELL

0

STRONG SELL

27

TOTAL · Buy

As of: 18/09/2026

ANALYST FIRMRATINGACTIONDATE
BarclaysOverweightmaintain18/09/2026
Deutsche BankBuymaintain31/08/2026
BTIGBuymaintain28/08/2026
BTIGBuymaintain24/07/2026
RBC CapitalOutperformmaintain03/06/2026
CitizensMarket Outperformmaintain01/06/2026
RBC CapitalOutperformmaintain29/05/2026
Barrington ResearchOutperformmaintain22/05/2026

HealthEquity stock metrics

P/E

32.87

P/B

3.86

EV/EBITDA

16.82

RETURN ON EQUITY

3.3%

NET MARGIN

18.7%

DEBT/EQUITY

0.49

DIVIDEND YIELD

0.0%

AS OF

31/07/2026

Free float & liquidity

FREE FLOAT

98.0%

FLOAT SHARES

81,021,287

AVG. DAILY VOLUME (30D)

855,895

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Cutler Scott

OfficerTax settlement1,23091.16Spontaneous08/10/2026

Gathright Michael

OfficerTax settlement66291.16Spontaneous08/10/2026

Fiore Michael Henry

InsiderTax settlement2,03291.16Spontaneous08/10/2026

Neeleman Stephen

OfficerTax settlement1,09591.16Spontaneous08/10/2026

Ladd Delano

OfficerTax settlement1,08091.16Spontaneous08/10/2026
Page 1 / 6

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
WASATCH ADVISORS LP7,011,469-949,26630/09/2026
DAVENPORT & Co LLC962,799-124,41930/09/2026
BEACON INVESTMENT ADVISORY SERVICES, INC.96,556+2,31930/09/2026
INSPIRION WEALTH ADVISORS, LLC65,000+030/09/2026
THOMPSON INVESTMENT MANAGEMENT, INC.64,010-53730/09/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about HealthEquity stock

What does HealthEquity do?

HealthEquity, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.

The CEO is Scott R. Cutler, the company employs around 2,814 people.

The IPO was on 31/07/2014; the stock trades on NASDAQ under the ticker HQY.

What do analysts say about HealthEquity stock?

27 analysts rate the stock, the consensus is Buy (as of 18/09/2026).

The average price target is US$117.00, ranging from US$108.00 to US$142.00, with a median of US$113.00.

This is an external assessment, not a statement by Market Jury.

When does HealthEquity report next?

The next earnings date is 02/12/2026.

Around past earnings, price swings were roughly 45% stronger than usual.

Does HealthEquity pay a dividend?

No, HealthEquity currently does not pay a dividend.

Which stocks are comparable to HealthEquity?

Comparable stocks include Hinge Health, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.

How can I get HealthEquity stock analyzed?

Clicking "Analyze stock" lets five strategies assess HealthEquity against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.